Showing 641 - 660 results of 1,715 for search '(( significant main decrease ) OR ( significant decrease decrease ))~', query time: 0.34s Refine Results
  1. 641
  2. 642
  3. 643
  4. 644
  5. 645

    Cis-acting elements in the promoter of PtWRKYs. by Yuzhao Ma (12840632)

    Published 2025
    “…The expansion of the poplar WRKY family mainly occurs through segmental duplication, and they also have abundant cross-species collinearity. …”
  6. 646

    The Ka/Ks values of PtWRKY paralogous gene pairs. by Yuzhao Ma (12840632)

    Published 2025
    “…The expansion of the poplar WRKY family mainly occurs through segmental duplication, and they also have abundant cross-species collinearity. …”
  7. 647

    RNA-seq data of WRKY genes. by Yuzhao Ma (12840632)

    Published 2025
    “…The expansion of the poplar WRKY family mainly occurs through segmental duplication, and they also have abundant cross-species collinearity. …”
  8. 648

    Analysis of PtWRKY genes. by Yuzhao Ma (12840632)

    Published 2025
    “…The expansion of the poplar WRKY family mainly occurs through segmental duplication, and they also have abundant cross-species collinearity. …”
  9. 649

    The primer sequences for RT-qPCR. by Yuzhao Ma (12840632)

    Published 2025
    “…The expansion of the poplar WRKY family mainly occurs through segmental duplication, and they also have abundant cross-species collinearity. …”
  10. 650
  11. 651
  12. 652
  13. 653
  14. 654
  15. 655

    Summary representation of the effects of <i>LGALS3</i> silencing on the main enzymes involved in lipid biosynthesis, storage, transport and by Francesca Sedda (16021610)

    Published 2025
    “…Reduction in neutral lipid content and type I collagen production in 3D spheroids observed following <i>LGALS3</i> knockdown was accompanied by a significant decrease in the mRNA levels of <i>DGAT1, CPT1A</i> and <i>PPARA</i>, evidenced in green. …”
  16. 656

    Participants’ characteristics. by Doris van der Smissen (20536881)

    Published 2025
    “…</p><p>Results</p><p>Four main themes were identified. First, cancer survivors reported an <i>emotional fallout episode</i> to often follow treatment, which was characterized by a loss of direction and control due to discontinuation of medical care, decreased support from healthcare professionals and their social network, and an emotional set back. …”
  17. 657
  18. 658

    Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

    Published 2024
    “…Skp1-CUL1-ROC1-F-box E3 ubiquitin ligases’ main component S-phase kinase-associated protein 2 (Skp2) is responsible for specifically recognizing ubiquitination-modified substrates to be degraded such as p27 and p21 in the case of binding with adaptor protein Cks1. …”
  19. 659

    Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

    Published 2024
    “…Skp1-CUL1-ROC1-F-box E3 ubiquitin ligases’ main component S-phase kinase-associated protein 2 (Skp2) is responsible for specifically recognizing ubiquitination-modified substrates to be degraded such as p27 and p21 in the case of binding with adaptor protein Cks1. …”
  20. 660

    Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

    Published 2024
    “…Skp1-CUL1-ROC1-F-box E3 ubiquitin ligases’ main component S-phase kinase-associated protein 2 (Skp2) is responsible for specifically recognizing ubiquitination-modified substrates to be degraded such as p27 and p21 in the case of binding with adaptor protein Cks1. …”